George Thomas, 29, points out that the industry was valued at £90 million in 2018 and is expected to reach almost £200 million this year. On top of this, he is convinced CBD (cannabidiol) oil is a great product that has helped thousands of people living with chronic health conditions. His company sells the highest quality Cannabis Sativa L extracts available in the UK.
At home on the family farm near Frome, George is excited at the prospect of building the business, launched in September 2017 with funding from his father’s investment company Sativa Investments PLC, which is the UK’s first public-listed cannabis investment company.
Sativa Investments (NEX:SATI) is the UK’s first medicinal cannabis investment vehicle. After investing in two North American businesses, it is now progressing a UK seed to consumer investment strategy with 100% ownership of businesses involved in the production, testing and compliance, research & development including pharmacology, commercialisation and sales & marketing of medicinal cannabis and cannabidiol products. Two UK businesses, George Botanicals and PhytoVista Laboratories, are already fully operational.